Showing 1 of 1 recruiting trials for “growth-delay-due-to-insulin-like-growth-factor-i-resistance”
RecruitingNCT00903110 ↗
Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD).
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →